Phase 1 study supports recommended phase 3 dose for investigational EGFR x HER3 antibody-drug conjugate in EGFR-mutated lung cancer
Reports and Proceedings
Reports and Proceedings
Latest News Releases
Updates every hour. Last Updated: 27-Oct-2026 09:16 ET (27-Oct-2026 13:16 GMT/UTC)
Reports and Proceedings
Pumitamig plus elfetabart drozuntecan shows encouraging early activity in small cell lung cancer
Reports and Proceedings
Extended-interval tarlatamab dosing shows consistent activity and safety in previously treated small cell lung cancer
Reports and Proceedings
Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC
Reports and Proceedings
Subcutaneous tarlatamab shows favorable safety profile and antitumor activity in extensive-stage small cell lung cancer
Reports and Proceedings
New ‘smart’ nanoparticles help the immune system better attack tumours
Peer-Reviewed Publication
FDA clears CU Anschutz clinical trial using engineered immune cells to fight colorectal cancer
Business Announcement
Obesity may remove a natural defense against breast cancer
Peer-Reviewed Publication
Chemotherapy alters ‘Darwinian battleground’ in our bodies
Peer-Reviewed Publication
Multimodal AI roadmaps the future of personalized cancer immunotherapy
Peer-Reviewed Publication